Jay T. Evans

Evans Jay currently serves as the Chief Scientific and Strategy Officer at Inimmune since May 2022 and has been a Research Professor and Director of the Center for Transnational Medicine at the University of Montana since January 2016. Previously, Evans held the position of President and CEO at Inimmune Corporation, focusing on immunomodulatory therapeutics for various diseases. Prior experience includes roles at GSK as an Investigator and Project Leader, where Evans contributed to vaccine adjuvant research, as well as postdoctoral research positions at the University of Texas Southwestern and St. Jude Children's Research Hospital, emphasizing HIV research and gene therapy systems. Educational qualifications include a Ph.D. in Molecular and Cellular Biology from Oregon State University and a Bachelor's Degree in Biology from Pacific Lutheran University.